---
search:
  boost: 2 
---

# Macrolides

This is a subcategory of Infectious Disease Agents.

## Decision Tree

- [Antibiotics - Macrolides - Eryped, Erythrocin Stearate, Erythromycin](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNlAyMjA5RVVPSlQzVkVUM1lJSERIWDJESCQlQCN0PWcu&topview=Preview)

## Formulary

Infectious Disease Agents: Antibiotics â€“ Macrolides

### Preferred

| Preferred      | Generic Name | Quantity | Time (Days) |
| :------------- | :----------- | :------: | :---------: |
| Azithromycin   |              |          |             |
| Clarithromycin |              |          |             |

### Non-Preferred

| Non-Preferred       | Generic Name | Quantity | Time (Days) |
| :------------------ | :----------- | :------: | :---------: |
| Eryped              |              |          |             |
| Erythrocin Stearate |              |          |             |
| Erythromycin        |              |          |             |

## Authorizations

**Length of Authorizations**: Based on indication

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **3 days** with at least **one preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Additional Information

- Requests may be authorized if:
    - The infection is caused by an organism resistant to ALL preferred antibiotics (must provide diagnosis and any culture/sensitivity results)
    - The patient is completing a course of therapy that was started in the hospital or other similar location or was started before Medicaid eligibility, only the remaining course will be authorized

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring, **AND** medical necessity for continued use

**AR** - All drugs: a PA is required for patients younger than 40 years

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=77)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=26)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
